{"title": "EL CONSUMO DE HIERBAS MEDICINALES COMO CAUSA DE HEPATOTOXICIDAD", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Bibliograf\u00eda del art\u00edculo\n1. Jorge O, Ferrero S, Isaguirre J. Hepatotoxicidad asociada al consumo de hierbas medicinales. Revista Digital de ASSCAT (Associaci\u00f3 Catalana de Malalts d'Hepatitis) julio 2010 (en prensa).\n2. Lewis J. Liver disease caused by anesthetics, toxins, and herbal preparations. En: Sleisenger and Fortdtran's gastrointestinal and liver disease. 9th Ed. Saunders, Philadelphia, pp. 1447-1459, 2010.\n3. Chitturi S, Farrel G. Hepatotoxic slimming agents and other herbal hepatotoxins. J Gastroenterol Hepatol 23:366-373, 2008.\n4. Navarro V. Herbal and dietary supplement hepatotoxicity. Sem Liver Dis 29:373-382, 2009.\n5. Strader D, Seeff L. Hepatotoxicity of herbal preparation. En Zakim and Boyer's Hepatology. 9th Edition, Saunders, Philadelphia, pp. 551-560, 2006.\n6. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 27:1847-1858, 2005.\n7. Chalasani N, Fontana R, Bonkovsky H, et al. Drug induced liver injury network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135:1924-1934, 2008.\n8. Seeff L. Herbal hepatotoxicity. Clin Liver Dis 11:577-596, 2007.\n9. Zuckerman M, Steenkamp U, Stewart M. Hepatic venooclusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique. J Clin Pathol 55:676-679, 2002.\n10. Rochon J, Protiva P, Seeff L, et al. Drug-induced liver injury network (DILIN). Reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury. Hepatology 48:1175-1183, 2008.\n11. Verma S, Thuluvath P. Complementary and alternative medicine in hepatology: Review of evidence of efficacy. Clin Gastroenterol Hepatol 5:408-416, 2007.\n12. Zimmerman H. Hepatotoxicity. 2nd Ed., Lippincot, Williams and Wilkins, Philadelphia, 1999.\n13. Guma C, Thome N, Viola L, et al. Tratamiento con \u00e1cido ursodeoxic\u00f3lico en la hepatitis por drogas: Resultados de un estudio piloto y controlado. Res\u00famenes del XII Congreso Argentino de Hepatolog\u00eda. Buenos Aires Jul 1-4, 2003.\n14. Faureau J, Ryu M, Braunstein G, et al. Severe hepatotoxicity associated with the dietary supplement Lipokinetix. Ann Intern Med 136:590-595, 2002.\n15. Schoepfer A, Engel A, Fattinger K, et al. Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 47:521-526, 2007.\n16. Graham-Brown R. Toxicity of Chinese herbal remedies. Lancet 340:673-674, 1992.\n17. Kane J, Kane S, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 36:146-147, 1995.\n18. Mazzanti G, Menniti-Ippolito F, Moro P, et al. Hepatotoxicity from green tea: A review of the literature and two unpublished cases. Eur J Clin Pharmacol 65:331-341, 2009.\n19. Lynch C, Folkers M, Hutson W. Fulminant hepatic failure associated with the use of black cohosh: A case report. Liver Transpl 12:989-992, 2006.\n20. Bras G, Jelliffe D, Stuart K. Veno-occlusive disease of the liver with nonportal type of cirrhosis, occurring in Jamaica. Arch Pathol 57:285-300, 1954.\n21. Jorge O, Jorge A. Hepatotoxicity associated with the ingestion of centella asi\u00e1tica. Rev Esp Enferm Dig 97:115-124, 2005.\n22. Sheikh N, Philen R, Loue L. Chaparral-associated hepatotoxicity. Arch Intern Med 157:913-919, 1997.\n23. Teschke R, Schwarzenboeck A, Hennermann K. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 20:1182-1193, 2008.\n24. Lekehal M, Pessayre D, Lereau J, et al. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furanoditerpenoids by cytochrome P450 3A depletes cytoskeleton - associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 24:212-218, 1996.\n25. Haouzi D, Lekehal M, Moreau A, et al. Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology 32:303-311, 2000.\n26. Anderson I, Mullen W, Meeker J, et al. Pennyroyal toxicity: Measurement of toxic metabolites in two cases and review of the literature. Ann Intern Med 124:726-734, 1996.", "language": null, "image": null, "pagetype": null, "links": ["../../dato/autorb.php/115530", "../../dato/autorb.php/115530#ap", "../../main/expinv.php", "http://www.siicsalud.com/tit/expertos.php/", "../../des/experto.php/115530.htm", null, "/main/gnovespe.php?buscado=GAS&principal=1", "/main/gnovespe.php?buscado=TTX&principal=1", "/main/gnovespe.php?buscado=ANA&principal=1", "/main/gnovespe.php?buscado=ATE&principal=1", "/main/gnovespe.php?buscado=DIL&principal=1", "/main/gnovespe.php?buscado=EPI&principal=1", "/main/gnovespe.php?buscado=MFA&principal=1", "/main/gnovespe.php?buscado=MIN&principal=1", "/main/gnovespe.php?buscado=NUT&principal=1", "/main/gnovespe.php?buscado=PED&principal=1", null, "javascript:window.history.go(-2)", "/", "../../main/acercade.php", "../../main/siicestr.php", "/mensajes/"]}